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Brain lesionBased on preclinical ﬁndings, cellular therapy has become a promising therapeutic approach for neonatal hypoxia–
ischemia (HI). However, before translation into the clinical setting, new and effective routes of cell delivery must
be determined. Intra-arterial (IA) delivery is an attractive route of cellular administration but has never been used
in neonatal HI rats. Aims: In this study,we investigated the feasibility of IA transplantation of humanumbilical cord
blood (HUCB) mononuclear cells for the treatment of long-term behavior dysfunction and brain lesion after neo-
natal HI. Main methods: Seven-day-old rats were subjected to a HI model and the animals received HUCB mono-
nuclear cells into the left common carotid artery 24 h after HI insult. Key ﬁndings: At 9 weeks post-HI, intra-
arterially transplanted HUCB mononuclear cells signiﬁcantly improved learning and long-term spatial memory
impairments when evaluated by the Morris water maze paradigm. There was no effect of neonatal HI insult or
IA procedure on body weight and onmotor coordination and balance when evaluated by the accelerating rotarod
test. Cellular transplantation by the IA route did not restore neonatal HI-induced brain damage according to
stereological volume assessment. Furthermore, HUCB mononuclear cells were tracked in the injured brain
and peripheral organs of HI transplanted-rats by nested polymerase chain reaction analysis at different time
points. Signiﬁcance: Our ﬁndings contribute to the translational knowledge of cell based-therapy in neonatal
HI and demonstrate for the ﬁrst time that IA transplantation into rat pups is a feasible route for cellular delivery
and prevents long-term cognitive deﬁcits induced by experimental neonatal HI.
© 2013 Elsevier Inc. All rights reserved.Introduction
Neonatal hypoxia ischemia (HI) remains an important cause of
mortality and is associatedwith a high incidence of life-long disabilities.
Unfortunately, the clinical treatment of HI is quite limited, and no
available intervention can effectively hinder the long-term sequelae
of HI insult (Johnston et al., 2011). Presently, only hypothermia has
some beneﬁcial effects in moderate-affected HI children born at term
and treated in a narrow therapeutic window (Shankaran, 2012). In the
preclinical context, there is increasing evidence that cell based-
therapy exhibits a neuroprotective effect against HI brain injury and sub-
sequent deleterious outcomes (Liao et al., 2013; Pimentel-Coelho et al.,
2012). According to the Baby STEPS (Baby Stem cell Therapeutics as
an Emerging Paradigm in Stroke) consortium, the design of preclinicals e Sinalização Celular, Instituto
ersidade Católica do Rio Grande
rdim Botânico, CEP 90619-900,
51 33203312.
ghts reserved.studies should closely approximate clinical trials to favor the transla-
tional potential of cell therapy in neonatal HI (Borlongan and Weiss,
2011). Additionally, the experimental design should consider and
determine the cell type, dose, timing of administration and the delivery
route. Despite these recommendations, intraparenchymal injection is
the most commonly used technique for cell delivery into the rodent
HI brain (de Paula et al., 2010). Intracerebroventricular administration
precludes systemic dissemination but fails due to the limited cell num-
bers that can be injected. The same trade-off can be observed with the
intracerebral (IC) route, where cells can be delivered directly to the tar-
get, but they are nonuniformly distributed which may cause additional
brain injury. As an alternative to the aforementioned methods, we and
others have used intravenous (IV) delivery to transplant cells into neo-
natal HI animals (de Paula et al., 2009, 2012; Yasuhara et al., 2010).
However, the IV route does not yield a large number of cells reaching
the brain, and the majority of transplanted cells are trapped within
the ﬁltering organs such as the lungs, liver, spleen and kidneys
(Fischer et al., 2009; Lappalainen et al., 2008). Non-conventional cell
delivery methods, such as intraperitoneal (Rosenkranz et al., 2012),
intracardiac (Lee et al., 2010) and intranasal (Donega et al., 2013)
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is reasonable to investigate alternative ways to deliver stem cells
for the treatment of neonatal HI.
The intra-arterial (IA) route has the advantage of selectively
targeting a larger number of cells to an injured brain area, bypassing
theﬁlter of the peripheral organs, and permits amultiple treatment par-
adigm (Misra et al., 2012). Additionally, it was demonstrated that cell
administration via IA delivery could spread cells uniformly throughout
the ischemic brain (Li et al., 2010; Walczak et al., 2008). Although
the IA transplantation of cells has numerous precedents in clinical
trials (Barbosa da Fonseca et al., 2010; Friedrich et al., 2011) and in
animal models of adult HI (Andres et al., 2011; Guzman et al., 2008;
Pendharkar et al., 2010), stroke (Brenneman et al., 2010; Chua et al.,
2011; Chung et al., 2009; Gutierrez-Fernandez et al., 2011; Kamiya
et al., 2008; Lappalainen et al., 2008; Li et al., 2001, 2010; Mitkari
et al., 2012; Ohta et al., 2006; Vasconcelos-dos-Santos et al., 2012;
Walczak et al., 2008; Zhang et al., 2012) and traumatic brain injury
(Lundberg et al., 2012; Osanai et al., 2012), it has never been tested
in neonatal HI rodents. Here we investigate for the ﬁrst time the use
of the IA route for the transplantation of human umbilical cord blood
(HUCB) mononuclear cells in a neonatal rat HI model. The HUCB mono-
nuclear cell fraction was chosen for this study since it is easily collected
withminimal ex vivo processing. Parameters such as long-termbehavior
impairment, body and cerebral weight, brain damage and cell migration
were evaluated.
Materials and methods
Neonatal hypoxia–ischemia model and experimental groups
All analyses were performed in a blinded set-up, and all experimental
procedures were performed with the approval of the Animal Care and
Ethics Committee of PUCRS, Rio Grande do Sul, Brazil (CEUA 09/00105).
A schedule of the surgical procedure, the treatment and tests of the ani-
mals is shown in Table 1. Neonatal HImodel was established as described
before (de Paula et al., 2012; Greggio et al., 2011; Rice et al., 1981). Brieﬂy,
the right common carotid artery of 7-day-oldWistar ratwas permanently
doubly ligated. After 3-hour recovery, the pups were subjected to a
humidiﬁed mixture of 8% O2 and 92% N2 at 37 °C for another 2 h. The
animals were randomly assigned into ﬁve experimental groups: sham-
operated rats (sham, n = 10), rats subjected to the HI model (HI,
n = 11), HI rats IA administered with vehicle (VEH, n = 9) and HI rats
IA transplanted with 1 × 106 (HI+106, n = 10) or 1 × 107 (HI+107,
n = 10) HUCB mononuclear cells. The rat pups from each litter were
randomly divided among the groups to avoid “litter effects” on the
study outcome. Besides, only male rat pups were used in our study in
order to avoid gender effects upon the histological and behavioral out-
comes. Following the hypoxic exposure, all of the pups were returned to
their dams for recovery. The sham-operated animals were anesthetized
with halothane, and the right common carotid artery was exposed but
did not receive ligation or hypoxia.
HUCB mononuclear cell preparation and IA transplantation
After obtaining informed consent, HUCB cellswere collected ex-utero
from healthy volunteers immediately after full-term delivery usingTable 1
Timeline of experimental procedures.
PND 7 Neonatal rats subjected to the hypoxia–ischemia model
PND 8 Intra-arterial administration of HUCB mononuclear cells or vehicle
PND 65–69 Training for spatial version of the Morris water maze (MWM)
learning task
PND 70 Probe test for the MWM and rotarod habituation
PND 71 Accelerated rotarod test
PND 72 Cerebral hemispheric volume assessmentsterile syringes containing 5000 UI of heparin. For the separation of
mononuclear cells, the obtained material was diluted in RPMI-1640
medium (1:1) (Gibco, Grand Island, NY, USA). The cells were resuspend-
ed and fractionated on a density gradient generated by centrifugation,
over a Ficoll-Paque solution with a density of 1.077 g/L (Histopaque
1077, Sigma Aldrich, St. Louis, MO, USA), at 400×g for 30 min at 25 °C.
The mononuclear fraction over the Ficoll-Paque layer was collected
and washed twice with Dulbecco's Phosphate Buffered Saline (DPBS)
(Gibco, Grand Island, NY, USA). The cell density was determined with a
Neubauer-counting chamber, and the number of viable cells was deter-
mined using the Trypan Blue 0.4% exclusion method. For the detection
of surface antigens, HUCB mononuclear cells were incubated with ﬂuo-
rescein isothiocyanate- (FITC) or phycoerythrin- (PE) conjugatedmono-
clonal antibody against CD45 (hematopoietic precursor cells), CD105
(bone marrow precursor cells), CD34 (hematopoietic and endothelial
precursor cells), and CD117 (hematopoietic precursor cells) (Becton
Dickinson Biosciences, San Jose, CA). Labeled cells were collected and
analyzed using a FACSCalibur ﬂow cytometer (BD Biosciences, Franklin
Lakes, NJ). The immunophenotypic analysis of mononuclear fraction de-
rived from HUCB revealed that 2.4% of the cells expressed CD34, 23.14%
expressed CD45, 50.41% expressed CD105, and 71.25% expressed CD117.
Taken together, the data showed that the isolated cord blood cells exhib-
ited a mixture of different cellular types, consistent with the literature
(de Paula et al., 2009, 2012). Twenty-four hours after HI insult, animals
received HUCBmononuclear cells (1 × 106 or 1 × 107 cells resuspended
in 50 μl of PBS) or vehicle delivered into the left (contralateral) common
carotid artery using an ultraﬁne 34 gauge microneedle (outer-Ø
0.20 mm, inner-Ø 0.10 mm; Nodegraf, Tokyo, Japan). For this procedure,
animals were anesthetized again, the previous neck suture was
carefully opened, and the left carotid artery was isolated from
adjacent tissue to facilitate the IA injection. Thereafter, the skin
was once again closed with a suture, and the animals were returned
to their dams for recovery.
Spatial version of the Morris water maze learning task
The animals were tested in the spatial version of the Morris water
maze (MWM) learning task beginning at PND 65. The MWM was un-
dertaken to investigate the impact of IA cellular transplantation upon
neonatal HI-induced spatial memory impairment as described previ-
ously (de Paula et al., 2012; Greggio et al., 2011; Venturin et al., 2011).
Brieﬂy, the spaced training protocol was performed for 5 successive
days. On each day, the rats received 8 consecutive training trials
during which the hidden platform was kept in a constant location.
A different starting location was used for each trial, which consisted
of a swim followed by a 30-s platform sit. Any rat that did not ﬁnd
the platform within 60 s was guided to it by the experimenter.
Memory retention was evaluated in a 60-s probe trial performed
in the absence of the escape platform 24 h after the last training
session.
Accelerated rotarod performance
At PND 71, the rotarod test was performed to measure motor
coordination and balance in the rats. An apparatus equipped with a
sensor that detected the fall and automatically stopped the timer was
used (EFF 411, Insight, SP, Brazil). One day prior to the test, all animals
were habituated to the apparatus using a protocol of three trials
of 3 min each at 16-rpm speed. One day after the habituation, the
speed of the rotarod was set to gradually increase from 4 to 37 rpm
over 6 min across ten phases (1–2: 16 rpm; 3–4: 20 rpm; 5–6:
25 rpm; 7–8: 28 rpm; 9–10: 37 rpm). Upon reaching the maximum
speed, the animals were kept in place for an additional minute. The
test session consisted of ﬁve trials separated by 15-minute intervals
(Daadi et al., 2010).
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After the accelerated rotarod test (PND 72), the animals were
weighed, deeply anesthetized with thiopental sodium (0.1 ml/100 g,
i.p.) and then perfused transcardially with saline followed by 4%
paraformaldehyde at 4 °C. The brains were histologically processed
and the hemispheric volumewas assessed by using the Cavalieri princi-
ple associated with the counting point method as described elsewhere
(Alles et al., 2010; de Paula et al., 2012).
Nested polymerase chain reaction (PCR) analysis
An additional group of HI+107 rats was euthanized and samples
from the right and left cerebral hemispheres, lungs, liver and spleen
were collected at 1, 3, 6, 12 and 24 h, and 7 and 30 days after IA trans-
plantation of HUCB mononuclear cells (n = 2 male rats for each time
point). PCR analysis was performed to identify the presence of the
administered HUCB mononuclear cells in the samples of transplanted
animals using complementary primers to the human β-actin gene
sequence. DNA isolation and nested-PCR analysis were performed as
described before (de Paula et al., 2012).
Statistical analysis
The statistical analysis was performed using PrismGraph 5.0 soft-
ware (Graph-Pad Software, San Diego, CA). Comparisons between the
experimental groups were made by using one-way ANOVA followed
by Dunnett's post hoc test or by using two-way ANOVA followed by
Bonferroni's post hoc test. A statistical signiﬁcance level of α = 0.05
and p b 0.05 was applied to all tests.
Results
IA transplantation of 1 × 107 HUCB mononuclear cells rescues long-term
spatial memory impairments in rats previously subjected to neonatal HI
To assess the effects of IA transplantation of HUCB mononuclear
cells on long-term spatial memory deﬁcits, we employed the MWM
paradigm. The mean escape latencies to the hidden platform decreased
as training progressed, and the experimental groups showed a distinct
performance over time (F(4,225) = 2.824, p = 0.0003, Fig. 1A). As
shown in Table 2, two-way ANOVA followed by Bonferroni's post hoc
test revealed a signiﬁcant difference between the HI and sham groups
throughout the entire 5-day training session. The HI group animals IA
administered with either vehicle or 1 × 106 HUCB mononuclear cells
had similar learning performances when compared with the HI only
group and were signiﬁcantly different from the sham rats. Conversely,Fig. 1. IA transplantation of 1 × 107 HUCB mononuclear cells reduced the injury-induced spa
hidden platform were obtained from a 5-day training session. (B) Mean escape latency of swim
inwhich theplatformhad been submerged during training. (D)Number of crossings over the fo
⁎⁎p b 0.01 and ⁎⁎⁎p b 0.001 versus sham and #p b 0.05, ##p b 0.01 and ###p b 0.001 versus Hthe animals subjected to neonatal HI injury and transplanted with
1 × 107 HUCB mononuclear cells learned differently from the sham
rats but performed better than the HI, Veh and HI+106 groups. Since a
dysfunction in the learning performance among the groups in the train-
ing session was veriﬁed, we also expected to ﬁnd some impairment in
the probe tests of the HI animals as a consequence of it. The probe test
was performed 24 h after the last training session in the absence of
the escape platform. One-way ANOVA followed by Dunnett's post hoc
test showed that the escape latency to swim over the previous position
of the escape platform was longer in the HI (42.45 ± 6.73 s, p b 0.01),
HI+106 (38.66 ± 6.67 s, p b 0.05) and Veh (45.24 ± 5.36 s, p b 0.01)
groups when compared with the sham group (14.96 ± 2.91 s,
p b 0.01 versus HI group) (Fig. 1B). Only the HI+107 group had a
tendency to a shorter time required to localize the platform position
(27.53 ± 6.93 s, p N 0.05 versus sham and HI groups). In addition, the
HI and Veh animals spent less time swimming in the target quadrant
that previously contained the escape platform (28.88 ± 5.35% and
29.55 ± 4.77%, respectively, p b 0.01) compared with the sham-
operated rats (57.22 ± 4.18%) (Fig. 1C). Neither HI group transplanted
with 1 × 106 or 1 × 107 HUCB mononuclear cells had any signiﬁcant
difference when compared with the sham group for the time spent in
the target quadrant (41.57 ± 4.86% and 48.38 ± 7.03%, respectively).
However, only the HI+107 group had a signiﬁcantly statistical differ-
ence when compared to HI animals (p b 0.05), demonstrating cognitive
impairment recovery. With respect to the number of crossings over the
former target position, all groups displayed signiﬁcantly lower values
than the shamanimals (6.10 ± 0.78) (Fig. 1D).However, this difference
wasmore evident in the HI (1.54 ± 0.45, p b 0.001), Veh (1.77 ± 0.66,
p b 0.001) and HI+106 (2.60 ± 0.87, p b 0.01) animals than in the
HI+107 group (3.30 ± 0.65, p b 0.05). No statistically signiﬁcant differ-
ences were observed for swimming speed among the experimental
groups, demonstrating that the results in the MWM probe test were
not inﬂuenced by any HI-induced motor impairment (Fig. 1E).
IA transplantation of HUCB mononuclear cells or vehicle does not induce
impairments in rotarod performance and body weight in adult rats
previously subjected to neonatal HI
In the present study, the rotarod test was performed to measure
motor coordination and balance in rats. Using an accelerating rotarod
protocol, there were no statistically signiﬁcant differences between
the HI group and the sham rats in themean time spent on the treadmill
(Fig. 2A) and mean phase in which the fall occurred (Fig. 2B). One-way
ANOVA followed by Dunnett's test showed that the HUCB-treated
and Veh animals performed equally in both variables analyzed in the
rotarod test when compared with the sham group. These results are in
agreement with the normal motor function observed in the evaluationtial memory impairment in hypoxic–ischemic rats. (A) The mean escape latencies to the
ming over the previous platform location. (C) Percentage of time searching the quadrant
rmer target position. (E)Mean swimming speed of the rats during the probe test. ⁎p b 0.05,
I in Dunnett's post hoc test after one-way ANOVA.
Table 2
Morris water maze acquisition performance.
Group Training session
1 2 3 4 5
Sham 43.7 ± 2.9⁎⁎ 28.8 ± 2.9⁎⁎⁎ 15.4 ± 1.9⁎⁎⁎ 11.8 ± 1.5⁎⁎⁎ 11.8 ± 1.1⁎⁎⁎
HI 52.1 ± 1.5†† 47.6 ± 2.0†††§§ 42.3 ± 1.4†††§§§ 36.0 ± 0.9†††§ 32.8 ± 1.2†††§
HI+106 54.5 ± 1.0†††§ 50.7 ± 0.9†††§§§ 40.0 ± 1.8†††§ 34.4 ± 2.0††† 32.2 ± 1.9†††§
HI+107 47.1 ± 2.5 38.0 ± 2.1††⁎⁎ 32.0 ± 2.3†††⁎⁎⁎ 28.5 ± 2.2†††⁎ 25.0 ± 2.3†††⁎
Veh 53.0 ± 1.9†† 52.2 ± 2.6†††§§§ 42.3 ± 1.5†††§§ 39.4 ± 1.7†††§§§ 32.5 ± 1.6†††§
Values represent themean ± S.E.M. (values in seconds). ⁎p b 0.05, ⁎⁎p b 0.01 and ⁎⁎⁎p b 0.001 vs. HI group; ††p b 0.01 and †††p b 0.001 vs. sham group; §p b 0.05, §§p b 0.01, §§§p b 0.001
vs. HI+107 group in Bonferroni post hoc test after two-way ANOVA.
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test, the animals were weighed and no signiﬁcant differences
were observed among the experimental groups, as sham (273.2 ±
42.6 g), HI (267.2 ± 21.5 g), HI+106 (250.8 ± 32.3 g), HI+107
(241.7 ± 34.49 g) andVeh (257.2 ± 26.0 g). Additionally, themortality
rate was the same between the control and the transplanted animals
(~15%).
IA transplanted HUCB mononuclear cells are not able to prevent brain
injury in adult rats previously subjected to neonatal HI
Wenext examinedwhether IA transplantation of HUCBmononuclear
cells could block the long-term brain morphological alterations by using
the Cavalieri principle and the counting point method. Morphological
examination of cresyl violet-stained sections of rat brains from the
sham group revealed no histological abnormalities or volume differ-
ences between the cerebral hemispheres (542.4 ± 10.17 versus
535.6 ± 9.13 mm3) (Fig. 3A and E). Conversely, absolute hemi-
spheric volume analysis showed signiﬁcant atrophy of the hemisphere
ipsilateral to the carotid occlusion (right side)when comparedwith the
contralateral hemisphere (551.1 ± 10.27 versus 385.4 ± 57.49 mm3,
p b 0.05) (Fig. 3A and F) 9 weeks after the HI injury. Similarly, the
HI+106 (Fig. 3A and G) and Veh (Fig. 3A and I) groups also had a signif-
icantly reduced right hemisphere volume when compared with the
left hemisphere (510.2 ± 18.43 versus 352.0 ± 66.95 mm3, p b 0.05;
and 570.7 ± 20.73 versus 396.1 ± 65.10 mm3, p b 0.05; respectively).
However, no statistically signiﬁcant difference was observed be-
tween the right and left hemispheres in HI rats IA transplanted
with 1 × 107 HUCB mononuclear cells (505.2 ± 13.47 versus
362.6 ± 67.25 mm3) (Fig. 3A and H). In a different analysis ap-
proach, we examined cerebral atrophy in terms of percentage ofFig. 2. Effect of IA transplantation of HUCB mononuclear cells or vehicle on rotarod
performance and body weight of adult rats previously subjected to neonatal HI. There
were no statistically signiﬁcant differences between the HI groups and the sham rats on
the mean time spent on the treadmill (A) and mean phase in which the fall occurred.
Data were analyzed by one-way ANOVA followed by the Dunnett's post hoc test.brain tissue loss (Fig. 3B). One-way ANOVA followed by Bonferroni's
post hoc test revealed no signiﬁcant difference between the sham
(1.22 ± 0.32%) and HI (30.21± 10.47%), HI+106 (33.99 ± 11.57%),
HI+107 (29.73 ± 12.48%) or Veh (32.02 ± 10.29%) groups. Based on
visual and histological investigation, the percent of porencephalic
cysts (~40%) was the same among transplanted and non-treated HI
animals. Corroborating this evidence, one-way ANOVA followed by
Dunnett's post hoc test demonstrated no signiﬁcant difference in brain
weight among the groups, but only when compared with sham animals
(p b 0.05) (Fig. 3C).
Human β-actin gene expression was detected in samples obtained from HI
rats IA transplanted with HUCB mononuclear cells
We employed nested PCR analysis to elucidate whether the ob-
served beneﬁcial cognitive effects were associated with the migration
of cells to the injured brain and tomonitor their spreading in the rodent
body. The expression of the band corresponding to the human β-actin
gene was initially detected (1 h post-transplantation) in the left cere-
bral hemisphere, liver and lungs of HI rats that received cellular admin-
istration into the left carotid artery. At 3 h after cellular transplantation,
human DNAwas detected in the liver and lungs and not detected in the
left hemisphere, but it was detected in the right injured brain hemi-
sphere. However, at 6 h post-transplantation, the human β-actin gene
was only ampliﬁed in the right hemisphere. We could not detect any
expression for the human gene in the brain or systemic organs at 24 h
after IA transplantation of HUCB mononuclear cells. At later analysis
timepoints,we could detect humanDNA in the left cerebral hemisphere
and lungs (7 and 30 days post-transplantation), and in the right hemi-
sphere (30 days post-transplantation). It was not possible to detect
the expression of human β-actin gene in the spleen of IA transplanted
HI rats at any time point analyzed.
Discussion
Here we demonstrate for the ﬁrst time that IA transplantation is a
feasible delivery route for cellular therapy in neonatal rats subjected
to a HI model. The IA delivered cells prevented cognitive impairments
9 weeks after neonatal HI insult but did affect recovery from brain dam-
age. Additionallywe further showed that HI insult or IA cell transplanta-
tion had no long-term impact on body weight or motor function in
rodents. HUCB mononuclear cells were rapidly identiﬁed in the ische-
mic brain after IA transplantation and also in several peripheral organs.
Altogether the data indicate that the IA approach is a potential delivery
method for cell based-therapy for neonatal HI.
The HUCB mononuclear cell fraction was chosen for this study
because these cells are one of the most convenient and rich sources of
therapeutic cells in pediatrics and can be used in the case of neonates
affected by HI insult. Cord blood is easily collected after delivery and
can be promptly used because it requires minimal ex vivo processing,
or it can be cryopreserved for a longer period in cord blood banks
(Liao et al., 2013).We have recently demonstrated that acute IV admin-
istration of HUCB mononuclear cells exerts a dose-dependent effect on
Fig. 3. IA transplantation of HUCB mononuclear cells is not able to prevent long-term brain injury in adult rats subjected to neonatal HI. (A) The estimated volumes of the contralateral
(white columns) and ipsilateral (gray columns) hemispheres. (B) Percentage of brain tissue loss. ⁎p b 0.05 vs. left hemisphere volume in Bonferroni's post hoc test after one-way
ANOVA. (C) Brain weight measurements. ⁎p b 0.05 vs. sham in Dunnett's post hoc test after one-way ANOVA. (D) A schematic drawing from the Paxinos and Watson's atlas (interaural
5.70 mm; bregma−3.30 mm). (E–I) Digitized images of the rat brains that corresponded to the coronal sections from the sham (E), HI (F), HI+106 (G), HI+107 (H) and Veh (I) groups.
Calibration bars = 1 mm.
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(de Paula et al., 2012). Therefore, HUCB mononuclear cells represent
a promising candidate for neonatal HI therapy. Nevertheless, the ideal
route for stem cell delivery is a key factor that needs to be addressed
in the preclinical context to help in the design of future clinical trials
for neonatal HI treatment (Borlongan and Weiss, 2011).
IA delivery route has never been used for cellular transplantation in
immature rats following neonatal HI insult. The main advantage of IA
transplantation is the possibility of directing a larger number of cells
to a speciﬁc injured brain area by a less invasive procedure than the
intraparenchymal injection.Moreover, this approach circumvents cellu-
lar entrapment by internal organs and allows for repetitive transplant
regimens (Misra et al., 2012). In the present study, the cell doses
and volumes were based on previously published studies (Gutierrez-
Fernandez et al., 2011; Kamiya et al., 2008; Lappalainen et al., 2008;
Walczak et al., 2008). We adapted the microneedle technique for cellu-
lar transplantation in neonatal rats. This technique uses the high rate of
blood ﬂow in the common carotid artery to dilute and carry the injected
single-cell suspension (Chua et al., 2011). In contrast to studies that had
shown that intra-carotid delivery of cells induces increasedmortality in
stroke animals (Li et al., 2010;Walczak et al., 2008), we found no differ-
ences in the mortality rate, body weight, motor function and left brain
hemisphere integrity among the experimental groups, indicating the
safety of microneedle-based injection method. The IA transplantation
was performed in the left common carotid artery, contralateral to the
injured brain hemisphere, because we used Rice's model of neonatal
HI in which the right common carotid artery is permanently occluded
and does not allow reperfusion (Rice et al., 1981). Some studies suggest
that transplanted cells migrate preferentially to the ischemic hemi-
sphere (Lundberg et al., 2012) and that chemoattraction may recruit
therapeutic cells through the interhemispheric vasculature, followed
by transendothelial diapedesis and subsequent intraparenchymal
migration to the HI brain lesion (Andres et al., 2011; Pendharkar et al.,
2010).
In this study, the IA transplantation of HUCB mononuclear cells
dose-dependently reduced cognitive deﬁcits induced by neonatal HI
brain injury. We have previously demonstrated the same beneﬁcial
effect on cognitive function using the IV route for HUCB mononuclearcell delivery (de Paula et al., 2012). According to our studies, the cellular
dose capable of promoting cognitive recovery in HI rats is lower with IA
transplantation thanwith IV (1 × 107 versus 1 × 108 cells, respectively)
transplantation. It was also demonstrated that 1 × 104 embryonic stem
cell-derived cells improve the learning ability and memory of HI mice
at 2 and 8 months after intracerebroventricular transplantation using
the MWM paradigm (Ma et al., 2007). Additionally, because the Veh
and HI rats had the same performance on the training session and the
probe tests of MWM, we can assume that the IA administration proce-
dure is safe and does not exacerbate the cognitive dysfunction found
in neonatal rats.
According to accelerating rotarod test, there was no signiﬁcant im-
pact of the neonatal HI model, IA administration of HUCB mononuclear
cells or vehicle on balance and motor coordination in adult rats. The
ﬁnding of normal locomotor activity in adult rats subject to neonatal
HI insult may be due to the spontaneous recovery of sensorimotor
deﬁcits because of plasticity of the immature brain (Balduini et al.,
2000; de Paula et al., 2012; Lubics et al., 2005; Rojas et al., 2012).
There is evidence for a positive effect of cell-based therapy on neonatal
HI-induced sensorimotor impairment using the IC (Daadi et al., 2010)
and IV (Yasuhara et al., 2010) routes. With regard to IA transplantation,
stem cells have been shown to recover sensorimotor deﬁcits in experi-
mental models of stroke (Kamiya et al., 2008; Ohta et al., 2006) and
traumatic brain injury (Osanai et al., 2012). A positive correlation was
demonstrated between the number of IA transplanted cells found in
the brain and the degree of motor recovery in the adult HI model
(Guzman et al., 2008). Conversely, two studies using the neonatal
HI model failed to demonstrate motor recovery in the rotarod test
by using IC (Yasuhara et al., 2006) and intra-cardiac (Lee et al., 2010)
delivery methods. In our study, intra-carotid transplantation was
unable to reduce brain damage independently of cognitive recovery in
the HI rats. It is possible that IA transplantation of HUCB mononuclear
cells enhances brain plasticity rather than neuroprotection. Similarly,
others have also shown functional recovery without brain injury reduc-
tion through IC (Daadi et al., 2010) and IA (Gutierrez-Fernandez et al.,
2011; Guzman et al., 2008; Zhang et al., 2012) cellular transplantation.
Interestingly, the greater brain engraftment of IA transplanted cells
may not necessarily be associated with higher brain lesion recovery in
38 S. Greggio et al. / Life Sciences 96 (2014) 33–39the stroke model (Gutierrez-Fernandez et al., 2011; Li et al., 2010;
Zhang et al., 2012). Intra-cardiac injection of mesenchymal stem cells
neither restores brain infarction nor improves the performance on
the rotarod test in neonatal HI (Lee et al., 2010). In contrast, IA delivery
of therapeutic cells favored both histological and cognitive outcomes
in adult HI (Andres et al., 2011) and stroke (Brenneman et al., 2010;
Kamiya et al., 2008; Ohta et al., 2006) models. Interestingly, the
transplantation of 1 × 107 HUCB mononuclear cells decreased infarc-
tion volume in animals receiving IV treatment (de Paula et al., 2012).
Conversely, the samedosage ofHUCBmononuclear cellswas not effective
against HI brain injury through IA cellular transplantation. Furthermore,
no further brain damage was identiﬁed in the ipsilateral hemisphere
due to HUCB transplantation, indicating the safety of the IA delivery
method.
We veriﬁed cellular migration to the injured brain hemisphere as
early as 3 and 6 h post-transplantation and also at 7 and 30 days later.
However, human cells were not detectable at 24 h after their IA admin-
istration into the neonatal rat brain. This evidence is debatable because
different sets of animals were used for each time point analyzed.
Furthermore, interindividual variability of the IA transplant efﬁciency
and degree of HI brain damage might have affected cellular migration
to the target injured brain (Li et al., 2010). We also detected human
cells in the liver and lungs at 1 and 3 h post-IA transplantation, which
is consistent with preclinical and clinical studies (Barbosa da Fonseca
et al., 2010; Vasconcelos-dos-Santos et al., 2012). PCR analyses are com-
monly used to investigate cell migration in preclinical studies (de Paula
et al., 2009, 2012; Venturin et al., 2011). However, the drawback of the
PCR technique lies in its inability to permit longitudinal studies in the
same animals. It has been shown in animal models of ischemic stroke
(Gutierrez-Fernandez et al., 2011; Kamiya et al., 2008; Lappalainen
et al., 2008; Li et al., 2010; Pendharkar et al., 2010; Walczak et al.,
2008; Zhang et al., 2012) and traumatic brain injury (Lundberg et al.,
2012) that IA delivery results in a wider distribution and larger number
of grafted cells in the injured brain than by IV injection. In contrast, a re-
cent study showed that IA and IV delivery routes provide similar brain
homing of bone marrow mononuclear cells in focal cerebral ischemia
(Vasconcelos-dos-Santos et al., 2012). Notwithstanding, it was demon-
strated that IA transplantation of stem cells after transient ischemia
results in a high variability of cell homing in the rat brain (Brenneman
et al., 2010; Lappalainen et al., 2008; Li et al., 2001; Walczak et al.,
2008). An explanation for this variability could be the ratio of the cell
diameter to the capillary size, which may affect the biodistribution
of transplanted cells into cerebral tissue (Lappalainen et al., 2008;
Walczak et al., 2008). Therefore, it is likely that IA injected cells become
initially entrapped in the cerebrovasculature due to cellular adhesion
and size and are then gradually recruited by chemotactic signals to the
ischemic tissue (Mitkari et al., 2012; Osanai et al., 2012; Vasconcelos-
dos-Santos et al., 2012).
The present study was not designed to investigate the mechanisms
of action by which HUCBmononuclear cells exert their neuroprotective
effects on HI neonatal rats. In contrast to the initial concept, studies in-
dicate that engraftment and direct differentiation of the transplanted
cells are not the key mechanisms of cell-based therapies. Currently,
it has been postulated that stem cells exert therapeutic effects
mediated by blood vessel regeneration, greater survival of intrinsic
cells, synaptic plasticity enhancement, anti-inﬂammatory action
and immunomodulation, most likely via neurotrophic factors
and cytokine secretion (Liao et al., 2013; Pimentel-Coelho et al.,
2012). Some studies suggest that only the presence of transplanted
HUCB cells within the systemic circulation is sufﬁcient for functional re-
covery and brain repair (Borlongan et al., 2004; Yasuhara et al., 2010).
Conversely, others point to the importance of stem cell engraftment
into the brain for behavioral improvement (Guzman et al., 2008).
It could therefore be hypothesized that the IA delivery route would
allow the convergence of systemic effects and the focal action of HUCB
mononuclear cells in the brain of HI animals.The femoral artery catheterization is not usual in the neonatal inten-
sive care units but it is eventually used for cardiac catheterization. In the
case of asphyxiated newborns, the procedure would be done in the ﬁrst
hours after birth through the umbilical artery which is performedwhen
attempts to obtain peripheral access are unsuccessful. The placement of
umbilical catheters has relatively low risk and is an essential technique
for the treatment of many newborns in unstable condition (Anderson
et al., 2008). Since the umbilical artery is usually available for two or
three days, the cellular transplantation would be performed before
that period. In the practice, we believe that the catheter could be intro-
duced until the carotid artery under echography monitoring for the
cellular transplantation, and after that the catheter would be placed in
its previous position (Berenstein et al., 1997). In another study from our
research group, asphyxiated piglets subjected to umbilical catheterization
for cellular transplantation had HUCB cells detected in their brains.
However, the HUCB cells were not detected when intravenous injection
was performed (data not published).
To our knowledge, this is the ﬁrst study to demonstrate the feasibil-
ity and protective effects of IA transplantation of HUCB mononuclear
cells in an experimental model of neonatal HI. Major factors such as
the aspects of the human cerebral vasculature and hemodynamics, the
dosage and infusion regimen, the adjuvant interventions and the cell
type and treatment timing will need to be addressed before translating
the IA approach for the delivery of stem cells into clinical applications.
It would be suitable to compare multiple routes of cell delivery using
the same neonatal HI model paradigm, assessments of brain lesions
and behavioral outcomes and cellular tracking by small animal imaging,
as performed elsewhere in experimental cerebral ischemia (Zhang et al.,
2012). Therefore, we propose that the IA route might provide an
additional alternative for cellular transplantation for pediatric patients
with HI injury.Conclusions
In this study, we show that IA transplantation is a feasible delivery
route for HUCB mononuclear cells in neonatal rats subjected to a HI
model. The IA delivered 1 x 107 cells hindered cognitive impairments
9 weeks after neonatal HI insult but did not protect against brain dam-
age. We further demonstrated that IA cellular transplantation is safe
since there was no long-term impact on bodyweight or motor function
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